PREVALENCE OF NAFLD IN THE GULF OF SIDRA, LIBYA

Home \ Archives\vol 2, No 1, 2026\ Articles

PREVALENCE OF NAFLD IN THE GULF OF SIDRA, LIBYA

DOI:10.64587/NOONSJ.v26i.2429

Volume (2), Issue (1) , June 2026

Published: 06/30/2026

Abstract: Currently the most common chronic liver condition, non-alcoholic fatty liver disease (NAFLD) is a major global health concern. Despite its rising global incidence, epidemiological data regarding NAFLD prevalence in Libya remain scarce. This cross-sectional study aimed to determine the prevalence of NAFLD among adults in Libya and evaluate its distribution across different age groups and genders. The study involved 200 participants of varying ages and genders recruited from a regional health center. Abdominal ultrasound was employed to screen for signs of fatty liver disease, and the collected data were analyzed using SPSS version 26. The results revealed higher prevalence of NAFLD in women (60.5%) compared to men (39.5%), with the highest prevalence rates observed in individuals aged 40 to 69 years. These findings indicate that NAFLD is becoming increasingly common both globally and within the local community. Consequently, there is an urgent need for enhanced awareness programs and effective management strategies at local, regional, and global levels to address this growing public health concern. ultrasonography, prevalence.

Keywords: Computed tomography; Pulmonary embolism; Sensitivity

References

Mayo Clinic (2023). Nonalcoholic fatty liver disease. https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease.

Chalasani, N., Younossi, Z., Lavine, J.E., Charlton, M., Cusi, K., Rinella, M., Harrison, S.A., Brunt, E.M., & Sanyal, A.J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance, Hepatology, 67(1), 328–357; https://doi.org/10.1002/hep.29367

Eslam, M., Newsome, P.N., Sarin, S.K., et al. (2020). A new definition for metabolic dysfunction-associated fatty liver disease. Journal of Hepatology, 73(1), 202–209; https://doi.org/10.1016/j.jhep.2020.03.039

Rinella, M.E. (2015). Nonalcoholic fatty liver disease: A systematic review. JAMA, 313(22), 2263–2273; https://doi.org/10.1001/jama.2015.5370

Bell, D., & Gaillard, F. (2025). Diffuse hepatic steatosis (grading). Radiopaedia.org. https://doi.org/10.53347/rID-12644.

Ye, D., Wang, J., Shi, J., et al. (2025). Prevalence of MAFLD in the US based on NHANES 2009–2018. BMC Gastroenterology, 25(1), 329; https://doi.org/10.1186/s12876-024-03412-x.

Arshad, T., Paik, J.M., Biswas, R., et al. (2021). NAFLD prevalence trends among adolescents and young adults. Hepatology Communications, 5(10), 1676–1688; https://doi.org/10.1002/hep4.1754

López-Velázquez, J.A., Silva-Vidal, K.V., Rodriguez, G.P., et al. (2014). The prevalence of NAFLD in the Americas. Annals of Hepatology, 13(2), 166–178; https://doi.org/10.1016/S1665-2681(19)30877-3 Younossi, Z.M., Golabi, P., Paik, J.M., et al. (2023). Global epidemiology of NAFLD and NASH. Hepatology, 77(4), 1335–1347; https://doi.org/10.1097/HEP.0000000000000004

Quek, J., Chan, K.E., Wong, Z.Y., et al. (2023). Global prevalence of NAFLD in overweight populations. The Lancet Gastroenterology & Hepatology, 8(1), 20–30; https://doi.org/10.1016/S2468-1253(22)00317-X

Dong, X., Li, J.M., Lu, X.L., et al. (2024). Global burden of NAFLD and NASH. Translational Gastroenterology and Hepatology, 9, 33. https://doi.org/10.21037/tgh-23-44

Perumpail, B.J., Khan, M.A., Yoo, E.R., et al. (2017). Clinical epidemiology of NAFLD. World Journal of Gastroenterology, 23(47), 8263–8276. https://doi.org/10.3748/wjg.v23.i47.8263

Huh, Y., Cho, Y.J., & Nam, G.E. (2022). Recent epidemiology and risk factors of NAFLD. Journal of Obesity & Metabolic Syndrome, 31(1), 17–28; https://doi.org/10.7570/jomes22021

Almansoury, Y., Abdel-Gawad, M., et al. (2023). Liver diseases in the Arab world: A scoping review. Global Gastroenterology, 1(1).https://doi.org/10.61331/gg.2023.v1i1.5

Aljadi, A.M., Alkhir, M.A., & Milad, M.H. (2020). Assessment of NAFLD in type 2 diabetic patients in Libya. Journal of Pure & Applied Sciences, 19(5), 96–102; https://doi.org/10.21608/jpas.2020.158575 Riazi, K., Azhari, H., et al. (2022).Prevalence and incidence of NAFLD worldwide. The Lancet Gastroenterology & Hepatology, 7(9), 851–861; https://doi.org/10.1016/S2468-1253(22)00165-0 European Association for the Study of the Liver (EASL), et al. (2016). Clinical Practice Guidelines for NAFLD. Diabetologia, 59(6), 1121–1140; https://doi.org/10.1007/s00125-016-3902-y

Fedchuk, L., Nascimbeni, F., Pais, R., Charlotte, F., Housset, C., & Ratziu, V. (2014). Performance of steatosis biomarkers. Alimentary Pharmacology & Therapeutics, 40(10), 1209–1222; https://doi.org/10.1111/apt.12963

Starekova, J., & Reeder, S.B. (2020). Liver fat quantification techniques. Abdominal Radiology, 45(11), 3386–3399. https://doi.org/10.1007/s00261-020-02559-y

Hernaez, R., Lazo, M., Vonekamp, S., Kamel, I., Brancati, F.L., Guallar, E., & Clark, J.M. (2011). Diagnostic accuracy of ultrasonography for fatty liver. Hepatology, 54(3), 1082–1090; https://doi.org/10.1002/hep.24452

Kramer, H., Pickhardt, P.J., Kliewer, K.A., Hernando, D., Chen, G.H., Zagzebski, J.A., & Reeder, S.B. (2017). Accuracy of liver fat quantification imaging techniques. American Journal of Roentgenology, 208(1), 92–100; https://doi.org/10.2214/AJR.16.16565